Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Sunrest Lifescience Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

53%

Sell Order Quantity

47%

Bid Price

Qty

35.10

1600

35.00

1600

33.00

1600

30.00

1600

30.00

1600

Bid Total

12800

Bid Price

Qty

38.75

1600

39.00

1600

39.00

1600

42.00

1600

43.00

1600

Bid Total

11200

Option Chain

Analyzes market sentiment, predicts Sunrest Lifescience Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Sunrest Lifescience - Outcome of Board Meeting

    30 Apr 2026, 6:08PM Sunrest Lifescience Limited has informed the Exchange regarding Outcome of Board Meeting held on April 30, 2026 for Dissolving the Right Issue and oth
  • Sunrest Lifescience has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    21 Apr 2026, 9:20AM As of March 2026, 53.50% is owned by Indian Promoters and 46.50% by Public. <p align=justify> Top five Promoters holding highest number of shares of S
  • Sunrest Lifescience - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

    20 Apr 2026, 6:35PM Sunrest Lifescience Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Quarter ended 31st March, 2026
  • Sunrest Lifescience - Related Party Transactions

    17 Apr 2026, 3:46PM Sunrest Lifescience Limited has informed the Exchange about related Party Transactions Non-applicability of Related Party Disclosure under Regulation
  • Sunrest Lifescience - Structural Digital Database

    14 Apr 2026, 12:18PM SDD Compliance Certificate for the Quarter ended 31st March, 2026
  • Sunrest Lifescience - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    14 Apr 2026, 12:13PM Sunrest Lifescience Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Sunrest Lifescience - Trading Window

    26 Mar 2026, 5:43PM Sunrest Lifescience Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulatio
  • Sunrest Lifescience - Copy of Newspaper Publication

    26 Mar 2026, 1:23PM Sunrest Lifescience Limited has informed the Exchange about Copy of Newspaper Publication
  • Sunrest Lifescience - Rights Issue

    19 Mar 2026, 11:42AM Sunrest Lifescience Limited has informed the Exchange that Board of Directors at its meeting held on March 19, 2026, has decided to issue equity share
  • Sunrest Lifescience - Copy of Newspaper Publication

    18 Mar 2026, 1:20PM Sunrest Lifescience Limited has informed the Exchange about Copy of Newspaper Publication for the Announcement of Record Date of the Right Issue.
  • Sunrest Lifescience - Rights Issue

    18 Mar 2026, 12:24PM Sunrest Lifescience Limited has informed the Exchange that Board of Directors at its meeting held on March 17, 2026, has decided to issue equity share
  • Sunrest Lifescience - Record Date

    17 Mar 2026, 6:50PM Sunrest Lifescience Limited has informed the Exchange that Record date for the purpose of Rights is 23-Mar-2026.
  • Sunrest Lifescience - Rights Issue

    17 Mar 2026, 6:49PM Sunrest Lifescience Limited has informed the Exchange that Board of Directors at its meeting held on March 17, 2026, has decided to issue equity share
  • Sunrest Lifescience - Outcome of Board Meeting

    13 Feb 2026, 6:26PM Sunrest Lifescience Limited has informed the Exchange regarding Outcome of Board Meeting held on February 13, 2026 for the purpose of raising of funds
  • Sunrest Lifescience - Trading Window

    10 Feb 2026, 4:02PM Sunrest Lifescience Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulatio

Key fundamentals

Evaluate the intrinsic value of Sunrest Lifescience Ltd stock 

Name March-25 March-24 March-23 March-22
Assets 22.3482 20.3451 5.2584 4.3103
Liabilities 22.3482 20.3451 5.2584 4.3103
Equity 4.2912 4.2912 3 0.01
Gross Profit 3 0.6891 2.8453 1.0878
Net Profit 1.9998 0.2257 2.0431 0.7771
Cash From Operating Activities 1.4259 -14.7975 1.1548 -0.4487
NPM(%) 6.03 0.76 8.29 2.89
Revenue 33.1224 29.4829 24.642 26.8875
Expenses 30.1224 28.7938 21.7967 25.7997
ROE(%) 6.31 0.71 6.45 2.45

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Sunrest Lifescience Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 753.90 3.03 44.77 0.00 301.39 0.66
Lotus Eye Hospital and Institute Ltd 115.91 -0.44 373.90 0.00 3.55 0.00
Vaishali Pharma Ltd 7.74 4.17 0.00 0.00 3.13 0.00
Astec Lifesciences Ltd 667.00 -6.40 0.00 0.00 -363.15 0.00

Company Info

The Company was originally incorporated as "Sunrest Lifescience Private Limited" as a Private Limited Company under the provisions of the Companies Act, 2013 vide Certificate of Incorporation dated October 30, 2017, issued by the Registrar of Companies, Ahmedabad, Gujarat. Subsequently, the Company was converted into a Public Limited Company pursuant to shareholders resolution passed at Extra-ordinary General Meeting of our Company held on March 09, 2023 and the name of the Company was changed to "Sunrest Lifescience Limited". A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company was issued by the Registrar of Companies, Ahmedabad on March 21, 2023. The Corporate Identification Number of the Company is U74999GJ2017PLC099606. The Company is engaged in the business of marketing and distribution of pharmaceutical products in the domestic market. The Company offers wide range of pharmaceutical formulations and products manufactured by third party manufacturers. The Company is engaged in the marketing of OTC generic pharmaceutical products in the domestic market through Super Stockist or Stockist. The company offer range of pharmaceutical products manufactured by third party manufacturers. The company operate in different States of India such as Maharashtra, Gujarat, Madhya Pradesh, Orissa and Rajasthan. The company have presence in these States through Trade Mark registered products and/or products under registration. We deal in Capsules, Tablets, Syrup, Ointment, Gel, Mouth wash, Solution, Suspension, Dry powders and Toothpaste. The product portfolio comprises of vide range of drugs like Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory drug. The company have 18 Registered Trademarks for 32 products.

The Company was originally incorporated as "Sunrest Lifescience Private Limited" as a Private Limited Company under the provisions of the Companies Act, 2013 vide Certificate of Incorporation dated October 30, 2017, issued by the Registrar of Companies, Ahmedabad, Gujarat. Subsequently, the Company was converted into a Public Limited Company pursuant to shareholders resolution passed at Extra-ordinary General Meeting of our Company held on March 09, 2023 and the name of the Company was changed to "Sunrest Lifescience Limited". A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company was issued by the Registrar of Companies, Ahmedabad on March 21, 2023. The Corporate Identification Number of the Company is U74999GJ2017PLC099606. The Company is engaged in the business of marketing and distribution of pharmaceutical products in the domestic market. The Company offers wide range of pharmaceutical formulations and products manufactured by third party manufacturers. The Company is engaged in the marketing of OTC generic pharmaceutical products in the domestic market through Super Stockist or Stockist. The company offer range of pharmaceutical products manufactured by third party manufacturers. The company operate in different States of India such as Maharashtra, Gujarat, Madhya Pradesh, Orissa and Rajasthan. The company have presence in these States through Trade Mark registered products and/or products under registration. We deal in Capsules, Tablets, Syrup, Ointment, Gel, Mouth wash, Solution, Suspension, Dry powders and Toothpaste. The product portfolio comprises of vide range of drugs like Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory drug. The company have 18 Registered Trademarks for 32 products.

Read More

Parent Organisation

Sunrest Lifescience Ltd.

Founded

30/10/2017

Managing Director

Mr.Nikhilkumar Yashvntlal Thakkar

NSE Symbol

SUNRESTSM

FAQ

The current price of Sunrest Lifescience Ltd is

The 52-week high for Sunrest Lifescience Ltd is

The market capitalization of Sunrest Lifescience Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Sunrest Lifescience Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Sunrest Lifescience Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Sunrest Lifescience Ltd shares.

The CEO of Sunrest Lifescience Ltd is Mr.Nikhilkumar Yashvntlal Thakkar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT